Groups urge EU to reconsider draft rules for assessing new treatment technologies
Plans to alter how new medical technologies are assessed for approval in the EU have been met with heavy criticism from industry groups.
Last month, the European Commission launched a consultation on a draft implementing act for health technology assessment, which closed on 2 April. The act is intended to set out rules for how stakeholders should interact with regulators during the assessment of new technologies.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.